We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Efficacy of Bevacizumab Monotherapy in Treatment of Metastatic Melanoma

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00139360
First Posted: August 31, 2005
Last Update Posted: August 27, 2015
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
Norwegian Cancer Society
Hoffmann-La Roche
Information provided by (Responsible Party):
Oddbjørn Straume, MD PhD, Haukeland University Hospital